These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21602283)

  • 1. Structural underpinnings of prion protein conversion.
    Apostol MI; Surewicz WK
    J Biol Chem; 2011 May; 286(21):le7; author reply Ie8. PubMed ID: 21602283
    [No Abstract]   [Full Text] [Related]  

  • 2. Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion.
    Hafner-Bratkovic I; Bester R; Pristovsek P; Gaedtke L; Veranic P; Gaspersic J; Mancek-Keber M; Avbelj M; Polymenidou M; Julius C; Aguzzi A; Vorberg I; Jerala R
    J Biol Chem; 2011 Apr; 286(14):12149-56. PubMed ID: 21324909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UV-light exposed prion protein fails to form amyloid fibrils.
    Thakur AK; Rao ChM
    PLoS One; 2008 Jul; 3(7):e2688. PubMed ID: 18628989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.
    Rouget R; Sharma G; LeBlanc AC
    J Biol Chem; 2015 Feb; 290(9):5759-71. PubMed ID: 25572400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper refolding of prion protein.
    Wong BS; Vénien-Bryan C; Williamson RA; Burton DR; Gambetti P; Sy MS; Brown DR; Jones IM
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1217-24. PubMed ID: 11027613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleated conformational conversion and the replication of conformational information by a prion determinant.
    Serio TR; Cashikar AG; Kowal AS; Sawicki GJ; Moslehi JJ; Serpell L; Arnsdorf MF; Lindquist SL
    Science; 2000 Aug; 289(5483):1317-21. PubMed ID: 10958771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.
    Sang JC; Lee CY; Luh FY; Huang YW; Chiang YW; Chen RP
    Prion; 2012; 6(5):489-97. PubMed ID: 22987112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphology and secondary structure of stable beta-oligomers formed by amyloid peptide PrP(106-126).
    Walsh P; Yau J; Simonetti K; Sharpe S
    Biochemistry; 2009 Jun; 48(25):5779-81. PubMed ID: 19476383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetracysteine-tagged prion protein allows discrimination between the native and converted forms.
    Gaspersic J; Hafner-Bratkovic I; Stephan M; Veranic P; Bencina M; Vorberg I; Jerala R
    FEBS J; 2010 May; 277(9):2038-50. PubMed ID: 20345906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosensing of lipid-prion interactions: insights on charge effect, Cu(II)-ions binding and prion oligomerization.
    Steunou S; Chich JF; Rezaei H; Vidic J
    Biosens Bioelectron; 2010 Dec; 26(4):1399-406. PubMed ID: 20692152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3-disulfide mutant of mouse prion protein expression, oxidative folding, reductive unfolding, conformational stability, aggregation and isomerization.
    Lu BY; Chang JY
    Arch Biochem Biophys; 2007 Apr; 460(1):75-84. PubMed ID: 17320038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and structural studies of the prion protein polymorphism.
    Petchanikow C; Saborio GP; Anderes L; Frossard MJ; Olmedo MI; Soto C
    FEBS Lett; 2001 Dec; 509(3):451-6. PubMed ID: 11749972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.
    Kundu B; Maiti NR; Jones EM; Surewicz KA; Vanik DL; Surewicz WK
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12069-74. PubMed ID: 14519851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
    Vanik DL; Surewicz WK
    J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
    Jones EM; Surewicz WK
    Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hydrophobic mutations in the H2-H3 subdomain of prion protein on stability and conversion in vitro and in vivo.
    Hafner-Bratkovič I; Gaedtke L; Ondracka A; Veranič P; Vorberg I; Jerala R
    PLoS One; 2011; 6(9):e24238. PubMed ID: 21909425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfide mapping reveals the domain swapping as the crucial process of the structural conversion of prion protein.
    Hafner-Bratkovič I; Jerala R
    Prion; 2011; 5(2):56-9. PubMed ID: 21555920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-oligomer interactions of the human prion protein are modulated by the polymorphism at codon 129.
    Gerber R; Voitchovsky K; Mitchel C; Tahiri-Alaoui A; Ryan JF; Hore PJ; James W
    J Mol Biol; 2008 Aug; 381(1):212-20. PubMed ID: 18597782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determinants in prion protein folding and stability.
    Benetti F; Biarnés X; Attanasio F; Giachin G; Rizzarelli E; Legname G
    J Mol Biol; 2014 Nov; 426(22):3796-3810. PubMed ID: 25280897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.